TopFunds

HCA Healthcare, Inc.

NYSE: HCA

Stock price

458.84 USD

(+0%) TODAY

Medical - Care Facilities
Financials

all figures in US$ Millions except per share data

Sections:

Periods:

View:

Format:

Actual
10 year cagr
Help
Where available up to 10y CAGR shown for absolute numbers 10y Average marked A shown for relative numbers such as margins
Fiscal
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Average (A)
Fiscal period end dates
Expand all rows
01Earnings per share
Help
Earnings per share = Net Income / Number of Shares Outstanding
5
7.3
6
10.7
10.1
10.9
21.2
19.2
19
22
28.4
19%
02Free cash flow per share
5.5
7.3
6.5
9
9.9
18.5
16.4
14
17
21.5
33.3
19.7%
03Dividends per share
-
-
-
1.4
1.6
0.4
1.9
2.2
2.4
2.6
2.9
-
04Dividends payout, %
-
-
-
12.9%
15.7%
4.1%
9%
11.6%
12.6%
12%
10%
-
PROFIT AND LOSS STATEMENT
05Revenue
39,678
41,490
43,614
46,677
51,336
51,533
58,752
60,233
64,968
70,603
75,600
6.7%
06% Change
-
-
-
-
-
-
-
-
-
-
-
6.7%
07Cost of revenue
(6,638)
(6,933)
(7,316)
(7,724)
(8,481)
(8,369)
(36,260)
(37,056)
(39,389)
(41,925)
(44,226)
20.9%
08Gross profit
33,040
34,557
36,298
38,953
42,855
43,164
22,492
23,177
25,579
28,678
31,374
(0.5)%
09% Margin
83.3%
83.3%
83.2%
83.5%
83.5%
83.8%
38.3%
38.5%
39.4%
40.6%
41.5%
63.5% A
10Operating expenses
(27,075)
(28,359)
(30,241)
(32,311)
(35,637)
(35,902)
(12,814)
(14,124)
(15,952)
(18,131)
(19,409)
(3.3)%
11% of Revenue
(68.2)%
(68.4)%
(69.3)%
(69.2)%
(69.4)%
(69.7)%
(21.8)%
(23.5)%
(24.6)%
(25.7)%
(25.7)%
(48.7)% A
12Operating Income
5,965
6,198
6,057
6,642
7,218
7,262
9,678
9,053
9,627
10,547
11,965
7.2%
13Income tax expense
(1,261)
(1,378)
(1,638)
(946)
(1,099)
(1,043)
(2,112)
(1,746)
(1,615)
(1,866)
(2,050)
5%
14Net Income
2,129
2,890
2,216
3,787
3,505
3,754
6,956
5,643
5,242
5,760
6,784
12.3%
15% Margin
5.4%
7%
5.1%
8.1%
6.8%
7.3%
11.8%
9.4%
8.1%
8.2%
9%
7.8% A
16Shares Outstanding
426.7
395.9
372.2
355.3
348.2
345.4
328.8
294.7
276.4
261.8
230.7
(6)%
17EPS Basic
5.3
7.8
6.3
11
10.3
11.1
21.5
19.4
19.2
22.3
28.6
18.3%
18EPS Diluted
5
7.3
6
10.7
10.1
10.9
21.2
19.2
19
22
28.4
19%
19EBITDA
7,526
8,483
8,202
9,368
9,664
9,735
14,252
13,290
12,721
13,896
15,603
7.6%
% Margin
19%
20.5%
18.8%
20.1%
18.8%
18.9%
24.3%
22.1%
19.6%
19.7%
20.6%
20.2% A
20Net Interest Income (expense)
(1,540)
(1,598)
(1,670)
(1,765)
(1,841)
(1,560)
(1,529)
(1,739)
(1,938)
(2,061)
(2,248)
3.9%
21Net Debt / EBITDA
4
3.6
3.9
3.4
3.6
3.2
2.5
3
3.2
3.1
3.2
3.3 A
BALANCE SHEET
ASSETS
Current Assets
22Cash & equivalents
741
646
732
502
621
1,793
1,451
908
935
1,933
1,040
3.5%
23Short-term investments
-
-
-
-
-
-
-
-
-
88
-
-
24Accounts receivable
5,889
5,826
6,501
6,789
7,380
7,051
8,095
8,891
9,958
10,751
10,867
6.3%
25Other current assets
1,163
1,111
1,171
1,190
1,346
1,464
2,010
1,776
2,013
1,904
-
-
26Inventory
1,439
1,503
1,573
1,732
1,849
2,025
1,986
2,068
2,021
1,738
1,652
1.4%
27Total Current Assets
9,232
9,086
9,977
10,213
11,196
12,333
13,542
13,643
14,927
16,414
13,559
3.9%
Non-Current Assets
28Net property, plant & equipment
15,014
16,352
17,895
19,757
24,549
25,223
26,176
27,640
29,922
31,545
31,141
7.6%
29Long-term investments
610
542
617
594
564
810
886
1,204
1,233
1,231
633
0.4%
30Other non-current assets
7,888
7,778
8,104
8,643
8,749
9,124
10,138
9,951
10,129
10,323
15,387
6.9%
31Total Non-Current Assets
23,512
24,672
26,616
28,994
33,862
35,157
37,200
38,795
41,284
43,099
47,161
7.2%
Total Assets
32,744
33,758
36,593
39,207
45,058
47,490
50,742
52,438
56,211
59,513
60,720
6.4%
LIABILITIES
Current Liabilities
32Accounts payable
2,170
2,318
2,606
2,577
2,905
3,535
4,111
4,239
4,233
4,276
4,659
7.9%
33Short-term debt
233
216
200
788
495
588
629
734
2,787
5,041
6,742
40%
34Other current liabilities
3,113
3,300
3,352
4,204
4,357
4,581
4,842
4,929
5,635
5,860
4,949
4.8%
35Total Current Liabilities
5,516
5,834
6,158
7,569
7,757
8,704
9,582
9,902
12,655
15,177
16,350
11.5%
Non-Current Liabilities
36Long-term debt
30,255
31,160
32,858
32,033
35,076
32,468
36,097
39,466
39,072
40,196
43,456
3.7%
37Other non-current liabilities
3,019
2,397
2,572
2,523
2,790
3,426
3,574
3,143
3,424
3,585
3,685
2%
38Total Non-Current Liabilities
33,274
33,557
35,430
34,556
37,866
35,894
39,671
42,609
42,496
43,781
47,141
3.6%
39Total Liabilities
38,790
39,391
41,588
42,125
45,623
44,598
49,253
52,511
55,151
58,958
63,491
5.1%
SHAREHOLDERS` EQUITY
40Common stock
4
4
4
3
3
3
3
3
3
3
2
(6.7)%
41Retained earnings / (deficit)
(7,338)
(6,968)
(6,532)
(4,572)
(2,351)
777
(532)
(2,280)
(1,352)
(2,115)
(5,724)
(2.5)%
42Accumulated other comprehensive income / (loss)
(265)
(338)
(278)
(381)
(460)
(502)
(404)
(490)
(425)
(387)
(305)
1.4%
43Noncontrolling interests
1,553
1,669
1,811
2,032
2,243
2,320
2,422
2,694
2,834
3,054
3,256
7.7%
44Total shareholders' equity
(6,046)
(5,633)
(4,995)
(2,918)
(565)
2,892
1,489
(73)
1,060
555
(2,771)
(7.5)%
45Total Liabilities and shareholders' Equity
32,744
33,758
36,593
39,207
45,058
47,490
50,742
52,438
56,211
59,513
60,720
6.4%
46Total Debt
30,488
31,376
33,058
32,821
35,571
33,056
36,726
40,200
41,859
45,237
50,198
5.1%
47Net Debt
29,747
30,730
32,326
32,319
34,950
31,263
35,275
39,292
40,924
43,304
49,158
5.2%
CASH FLOW STATEMENT
CASH FLOWS FROM OPERATING ACTIVITIES
48Net income (loss)
2,129
2,890
2,216
3,787
3,505
3,754
6,956
5,643
5,242
5,760
6,784
12.3%
49Depreciation & amortization
1,904
1,966
2,131
2,278
2,596
2,721
2,853
2,969
3,077
3,312
3,523
6.4%
50Share-based compensation expense
239
251
270
268
347
362
440
341
-
360
-
-
51Changes in working capital and other assets
462
546
809
428
1,154
2,395
(1,290)
(431)
1,112
1,082
2,329
17.6%
52Net cash flows from operating activities
4,734
5,653
5,426
6,761
7,602
9,232
8,959
8,522
9,431
10,514
12,636
10.3%
CASH FLOWS FROM INVESTING ACTIVITIES
53Purchases of property, plant and equipment
(2,375)
(2,760)
(3,015)
(3,573)
(4,158)
(2,835)
(3,577)
(4,395)
(4,744)
(4,875)
(4,944)
7.6%
54Purchases of investments / marketable securities
-
-
-
-
(25)
(20)
(117)
(14)
-
-
-
-
55Proceeds from maturities of marketable securities
-
-
-
57
25
20
117
14
-
-
72
-
56Other investing activities
(208)
(480)
(1,264)
(385)
(1,562)
(558)
934
1,006
(573)
(58)
(116)
(5.7)%
57Net cash flows from investing activities
(2,583)
(3,240)
(4,279)
(3,901)
(5,720)
(3,393)
(2,643)
(3,389)
(5,317)
(4,933)
(4,988)
6.8%
CASH FLOWS FROM FINANCING ACTIVITIES
58Issuance (repurchases) of common stock, net
(2,397)
(2,751)
(2,051)
(1,530)
(1,031)
(441)
(8,215)
(7,000)
(3,811)
(6,042)
(10,067)
15.4%
59Dividends paid, net
-
-
-
(487)
(550)
(153)
(624)
(653)
(661)
(690)
(679)
-
60Debt issuance (repayments), net
778
815
1,509
(344)
567
(3,217)
3,255
3,287
1,295
3,205
3,208
15.2%
61Other financing activities
(357)
(572)
(519)
(714)
(757)
(866)
(1,071)
(1,290)
(917)
(1,055)
(1,012)
11%
62Net cash flows from financing activities
(1,976)
(2,508)
(1,061)
(3,075)
(1,771)
(4,677)
(6,655)
(5,656)
(4,094)
(4,582)
(8,550)
15.8%
63Increase (decrease) in cash and cash equivalents
175
(95)
86
(230)
119
1,172
(342)
(543)
27
998
(893)
-
64Cash and equivalents, ending balance
741
646
732
502
621
1,793
1,451
908
935
1,933
1,040
3.5%
65Free Cash Flow to the Firm (FCFF)
Help
Free Cash Flow to the Firm = Cash Flows from Operating Activities - Capital Expenditures
2,359
2,893
2,411
3,188
3,444
6,397
5,382
4,127
4,687
5,639
7,692
12.6%

Annual Reports, Presentations And IR Contacts

Go to the website
Annual report links (10K)
2025202420232022202120202019201820172016

HCA Healthcare, Inc. (HCA) financial statements and performance

Explore HCA Healthcare, Inc. (HCA) annual and quarterly financial statements, including revenue, operating income, net income, cash flow, assets, liabilities, and per-share metrics.

Compare reporting periods and financial trends to evaluate profitability, balance-sheet strength, cash generation, and long-term business performance.